Page
%P
-
Article
Open AccessSymptom relief and not cyst reduction determines treatment success in aspiration sclerotherapy of hepatic cysts
To assess whether quantitative assessment of symptom reduction is a better outcome parameter than cyst volume reduction for treatment success in patients treated by aspiration sclerotherapy.
-
Article
Open AccessPasireotide does not improve efficacy of aspiration sclerotherapy in patients with large hepatic cysts, a randomized controlled trial
We tested whether complementary use of the somatostatin analogue pasireotide would augment efficacy of aspiration sclerotherapy of hepatic cysts.
-
Article
Open AccessPredictors of treatment response following aspiration sclerotherapy of hepatic cysts: an international pooled analysis of individual patient data
To identify predictive variables of treatment response following aspiration sclerotherapy of large symptomatic hepatic cysts.